|
End-of-day quote
Korea S.E.
2026-08-28
|
5-day change | 1st Jan Change | ||
| 10,090.00 KRW | +14.14% |
|
+24.26% | -28.13% |
| 12-02 | Shinpoong Pharmaceutical Co.,Ltd announced that it has received KRW 11.5 billion in funding | CI |
| 11-25 | Shinpoong Pharmaceutical to divest 11.5 billion won worth of own shares | RE |
Company Valuation: Shinpoong Pharmaceutical Co.,Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 6,353,533 | 1,653,859 | 1,124,818 | 707,263 | 539,247 | 738,559 |
| Change | - | -73.97% | -31.99% | -37.12% | -23.76% | 36.96% |
| Enterprise Value (EV) 1 | 6,164,679 | 1,562,338 | 1,070,830 | 692,834 | 537,383 | 722,909 |
| Change | - | -74.66% | -31.46% | -35.3% | -22.44% | 34.52% |
| P/E | 1,307x | -147x | -31.9x | -12.6x | -35.7x | 81.8x |
| PBR | 16.8x | 4.56x | 3.29x | 2.57x | 2.06x | 2.56x |
| PEG | - | 0x | -0x | -0.2x | 0.5x | -1x |
| Capitalization / Revenue | 32.1x | 8.74x | 5.37x | 3.53x | 2.44x | 3.15x |
| EV / Revenue | 31.2x | 8.26x | 5.12x | 3.46x | 2.43x | 3.08x |
| EV / EBITDA | 309x | -958x | -50.5x | -19.5x | -106x | 28.2x |
| EV / EBIT | 796x | -109x | -31.5x | -14.6x | -31.6x | 50.7x |
| EV / FCF | 88x | -32.1x | -65.4x | -25.9x | -104x | 83.8x |
| FCF Yield | 1.14% | -3.12% | -1.53% | -3.86% | -0.96% | 1.19% |
| Dividend per Share 2 | 100 | - | - | - | - | - |
| Rate of return | 0.08% | - | - | - | - | - |
| EPS 2 | 94.85 | -217.8 | -663.9 | -1,075 | -289.1 | 171.6 |
| Distribution rate | 105% | - | - | - | - | - |
| Net sales 1 | 197,751 | 189,237 | 209,288 | 200,229 | 221,094 | 234,681 |
| EBITDA 1 | 19,954 | -1,631 | -21,215 | -35,484 | -5,066 | 25,648 |
| EBIT 1 | 7,746 | -14,306 | -34,019 | -47,392 | -17,029 | 14,255 |
| Net income 1 | 5,003 | -11,584 | -35,377 | -57,325 | -15,387 | 8,825 |
| Net Debt 1 | -188,854 | -91,521 | -53,988 | -14,430 | -1,864 | -15,650 |
| Reference price 2 | 124,000.00 | 31,950.00 | 21,150.00 | 13,520.00 | 10,310.00 | 14,040.00 |
| Nbr of stocks (in thousands) | 51,262 | 51,262 | 51,262 | 51,262 | 51,262 | 51,262 |
| Announcement Date | 3/23/21 | 3/17/22 | 3/23/23 | 3/21/24 | 3/20/25 | 3/20/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 378M | |
| 35.43x | 6.66x | 23.08x | 0.89% | 48.2B | |
| 18.31x | 2.21x | 9.9x | 1.43% | 39.97B | |
| 28.56x | 4.06x | 16.85x | 0.57% | 12.43B | |
| 27.71x | 3.37x | 17.45x | 0.91% | 12.03B | |
| 19.17x | 3.41x | 11.88x | 3.76% | 9.35B | |
| 9.79x | 2.26x | 5.85x | 4.42% | 7.75B | |
| 30.59x | 4.01x | 18.65x | 0.15% | 7.43B | |
| 15.85x | 2.08x | 6.73x | 3.19% | 7.22B | |
| Average | 23.17x | 3.51x | 13.80x | 1.92% | 16.08B | |
| Weighted average by Cap. | 25.80x | 4.12x | 15.73x | 1.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A019170 Stock
- Valuation Shinpoong Pharmaceutical Co.,Ltd
Select your edition
All financial news and data tailored to specific country editions
